Document Classification

Section Type: RESULTS

Text: Results of an intent-to-treat analysis did not meet the prespecified criterion for noninferiority but did demonstrate the superiority of continuous-dose terbinafine for : mycological cure of the target toenail (70. 9 % [105/148] vs 58. 7 % [84/143] ; P =. 03, relative risk [RR] of 1. 21 [95 % confidence interval (CI), 1. 02-1. 43]) ; clinical cure of the target toenail (44. 6 % [66/148] vs 29. 3 % [42/143] ; P =. 007, RR = 1. 52 [95 % CI, 1. 11-2. 07) ; complete cure of the target toenail (40. 5 % [60/148] vs 28. 0 % [40/143] ; P =. 02, RR = 1. 45 [95 % CI, 1. 04-2. 01) ; and complete cure of all 10 toenails (25. 2 % [36/143] vs 14. 7 % [21/143] ; P =. 03, RR = 1. 71 [95 % CI, 1. 05-2. 79).